After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business.
from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2VXdi6e
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» CCI approves GSK, Pfizer consumer healthcare JV formation
0 comments:
Post a Comment